This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Compound Screening Remove Screening Hits Remove Trials Related Topics
Biophysical Assays Fragment Screening Biochemical Assays Computational Chemistry Assay Development Protein Production Small Molecule Drug Development Pharmaceuticals Treatment More Related Topics >
article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

NOVEMBER 1, 2023

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We need to build the assays that we need for compound screening.

Fragment Screening 96
Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024